China Healthcare SECTOR OVERVIEW: biotech innovation boosts CRO/CMO M&A - Analysis

Date: Aug 2018
This is an overview of the CRO/CMO sector in China, which Mergermarket Journalist Jane He believes will see continued M&A in the coming years. This analysis features insight from two industry executives and one sector investor, as well as a selection of companies and deals to be aware of.
The information on this page may have been provided by a contributor to ChinaGoAbroad, and ChinaGoAbroad makes no guarantees about the accuracy of any content. All content shall be used for informational purposes only. Contributors must obtain all necessary licenses and/or ownership rights from the relevant content owner(s) before submitting such content (including texts, pictures, photos and diagrams) to ChinaGoAbroad for publication. ChinaGoAbroad disclaims all liability arising from the publication of any content/information (such as texts, pictures, photos and diagrams that infringe on any copyright) received from contributors. Links may direct to third party sites out of the control of ChinaGoAbroad, and such links shall not be considered an endorsement by ChinaGoAbroad of any information contained on such third party sites. Please refer to our Disclaimer for more details.